Skip to main content

Table 2 Participant characteristics separated by brain amyloid status

From: A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

 

Amyloid Negative (N = 253)

Amyloid Positive (N = 161)

Age (P < 0.0001)

 Mean (SD) [N]

67.7 (8.1) [253]

73.6 (7.4) [161]

Sex (P = 0.0139)

 Female [N]

63.6% [253]

50.9% [161]

Ethnicity (P = 0.5734)

 Hispanic [N]

21.7% [198]

24.5% [110]

Race

 White

176

97

 Black or African American

8

5

 Asian

2

0

 American Indian or Alaska Native

1

1

Education (P = 0.4080)

 Mean years (SD) [N]

16.3 (2.4) [170]

16.1 (2.5) [85]

ApoE4 distribution within subgroup

 No E4 [N]

71.5% [181]

32.3% [52]

 One E4 [N]

21.7% [55]

50.9% [82]

 Two E4 [N]

6.7% [17]

16.8% [27]

CDR (P < 0.0001)

 Percent CDR = 0 [N]

79.8% [84]

32% [75]

MMSE (P < 0.0001)

 Percent MMSE = 27–30 [N]

95.4% [152]

60.6% [71]

 mean (sd)

29.4 (1.6)

26.2 (4.5)

Abeta42/40 (P < 0.0001)

 mean (sd)

0.101 (0.010)

0.090 (0.010)

 min

0.072

0.059

 max

0.126

0.148

Abeta42 (pg/mL) (P < 0.0001)

 mean (sd)

44.477 (8.637)

40.421 (9.698)

 min

10.984

23.985

 max

82.494

103.882

Abeta40 (pg/mL) (P = 0.22)

 mean (sd)

440.435 (81.870)

452.325 (103.933)

 min

134.985

270.455

 max

893.672

1219.238

  1. N Number of total observations - not all demographic data were available from each cohort, so [N] is the number of participants where data was available/provided